AAAAAA
Results:
1-13
|
Results: 13
Authors:
VANASPEREN J
VANTELLINGEN O
BEIJNEN JH
Citation: J. Vanasperen et al., DETERMINATION OF DOXORUBICIN AND METABOLITES IN MURINE SPECIMENS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 712(1-2), 1998, pp. 129-143
Authors:
VANASPEREN J
VANTELLINGEN O
VANDERVALK MA
ROZENHART M
BEIJNEN JH
Citation: J. Vanasperen et al., ENHANCED ORAL ABSORPTION AND DECREASED ELIMINATION OF PACLITAXEL IN MICE COTREATED WITH CYCLOSPORINE-A, Clinical cancer research, 4(10), 1998, pp. 2293-2297
Authors:
VANASPEREN J
VANTELLINGEN O
BEIJNEN JH
Citation: J. Vanasperen et al., THE PHARMACOLOGICAL ROLE OF P-GLYCOPROTEIN IN THE INTESTINAL EPITHELIUM, Pharmacological research, 37(6), 1998, pp. 429-435
Authors:
VANASPEREN J
VANTELLINGEN O
TIJSSEN F
SCHINKEL AH
BEIJNEN JH
Citation: J. Vanasperen et al., EFFECTS OF DOXORUBICIN (DOX) ON HEPATOCYTE VOLUME REGULATION AND THE EXCRETION OF DOX UNDER HYPOTONIC CONDITIONS, Annals of oncology, 9, 1998, pp. 567-567
Authors:
VANASPEREN J
VANTELLINGEN O
TIJSSEN F
SCHINKEL AH
BEIJNEN JH
Citation: J. Vanasperen et al., INCREASED ACCUMULATION OF DOXORUBICIN AND DOXORUBICINOL IN CARDIAC TISSUE OF MICE LACKING MDR1A P-GLYCOPROTEIN, Annals of oncology, 9, 1998, pp. 569-569
Authors:
VANASPEREN J
VANTELLINGEN O
SCHINKEL AH
BEIJNEN JH
Citation: J. Vanasperen et al., COMPARATIVE PHARMACOKINETICS OF VINBLASTINE AFTER A 96-HOUR CONTINUOUS-INFUSION IN WILD-TYPE MICE AND MICE LACKING MDR1A P-GLYCOPROTEIN, Annals of oncology, 9, 1998, pp. 570-570
Authors:
VANASPEREN J
VANTELLINGEN O
VANDERVALK MA
ROZENHART M
BEIJNEN JH
Citation: J. Vanasperen et al., ENHANCED ORAL ABSORPTION AND DECREASED ELIMINATION OF PACLITAXEL IN MICE CO-TREATED WITH CYCLOSPORINE-A, Annals of oncology, 9, 1998, pp. 571-571
Authors:
VANTELLINGEN O
NOOIJEN WJ
SCHAAF LJ
VANDERVALK M
VANASPEREN J
HENRAR REC
BEIJNEN JH
Citation: O. Vantellingen et al., COMPARATIVE PHARMACOLOGY OF THE NOVEL CYCLOPROPYLPYRROLOINDOLE-PRODRUG CARZELESIN IN MICE, RATS, AND HUMANS, Cancer research, 58(11), 1998, pp. 2410-2416
Authors:
SPARREBOOM A
VANASPEREN J
MAYER U
SCHINKEL AH
SMIT JW
MEIJER DKF
BORST P
NOOIJEN WJ
BEIJNEN JH
VANTELLINGEN O
Citation: A. Sparreboom et al., LIMITED ORAL BIOAVAILABILITY AND ACTIVE EPITHELIAL EXCRETION OF PACLITAXEL (TAXOL) CAUSED BY P-GLYCOPROTEIN IN THE INTESTINE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(5), 1997, pp. 2031-2035
Authors:
VANASPEREN J
MAYER U
VANTELLINGEN O
BEIJNEN JH
Citation: J. Vanasperen et al., THE FUNCTIONAL-ROLE OF P-GLYCOPROTEIN IN THE BLOOD-BRAIN-BARRIER, Journal of pharmaceutical sciences, 86(8), 1997, pp. 881-884
Authors:
VANASPEREN J
VANTELLINGEN O
SPARREBOOM A
SCHINKEL AH
BORST P
NOOIJEN WJ
BEIJNEN JH
Citation: J. Vanasperen et al., ENHANCED ORAL BIOAVAILABILITY OF PACLITAXEL IN MICE TREATED WITH THE P-GLYCOPROTEIN BLOCKER SDZ-PSC-833, British Journal of Cancer, 76(9), 1997, pp. 1181-1183
Authors:
VANASPEREN J
SCHINKEL AH
BEIJNEN JH
NOOIJEN WJ
BORST P
VANTELLINGEN O
Citation: J. Vanasperen et al., ALTERED PHARMACOKINETICS OF VINBLASTINE IN MDR1A P-GLYCOPROTEIN-DEFICIENT MICE, Journal of the National Cancer Institute, 88(14), 1996, pp. 994-999
Authors:
MAYER U
WAGENAAR E
BEIJNEN JH
SMIT JW
MEIJER DKF
VANASPEREN J
BORST P
SCHINKEL AH
Citation: U. Mayer et al., SUBSTANTIAL EXCRETION OF DIGOXIN VIA THE INTESTINAL-MUCOSA AND PREVENTION OF LONG-TERM DIGOXIN ACCUMULATION IN THE BRAIN BY THE MDR1A P-GLYCOPROTEIN, British Journal of Pharmacology, 119(5), 1996, pp. 1038-1044
Risultati:
1-13
|